PREDICTIVE TECHNOLOGY GROUP, INC. (OTCMKTS:PRED) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02-Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(a)
Financial statements of business acquired. Not applicable.
(b)
Pro forma financial information. Not applicable.
(c)
Shell company transactions. Not applicable.
(d)
Exhibits.
17.1 Letter of Resignation- Ferguson
99.1 Press Release New Directors- Hatch and Barhorst
____________
PREDICTIVE TECHNOLOGY GROUP, INC. Exhibit
EX-17 2 ex17.htm RESIGNATION LETTER Converted by EDGARwiz Exhibit 17.1 Merle Ferguson March 18,…
To view the full exhibit click here
About PREDICTIVE TECHNOLOGY GROUP, INC. (OTCMKTS:PRED)
Predictive Technology Group, Inc. is engaged in the business of developing and implementing medical solutions to various aliments, which commonly afflict individuals domestically and around the world. The Company is focused on identifying, developing, acquiring and commercializing medical apparatuses and treatments. Its subsidiaries include Predictive Therapeutics, LLC, LifeCode Genetics, Inc. and Predictive Biotech, Inc. Predictive Therapeutics, LLC revolutionizes the treatment of serious and debilitating diseases through the commercialization of therapeutics leveraged by gene-based companion diagnostics. It uses gene-based information as the cornerstone in the development of diagnostics that assess a person’s risk of disease and therapeutic products designed to prevent and/or treat the disease. LifeCode Genetics, Inc. develops and commercializes gene-based diagnostics. Predictive Biotech, Inc. is in the business of creating treatments utilizing the advancements in cellular biology.